Blinding and randomization
In our study, we randomly assigned participants to receive either colchicine or a placebo for 5 days based on their informed consent agreement (patients who agreed to late PCI will join the late PCI group, and those who refused the late PCI will join the No Revas group). Tablets for colchicine (manufactured by Pratapa Nirmala (Fahrenheit), Indonesia) and the placebo (prepared by the pharmacy department of Saiful Anwar General Hospital) had the exact same color, design, and packaging. The patients, doctor, and pharmacist who conducted the study’s evaluation were all unaware of the intervention’s assignment.